344 related articles for article (PubMed ID: 26239127)
1. HPV Carcinomas in Immunocompromised Patients.
Reusser NM; Downing C; Guidry J; Tyring SK
J Clin Med; 2015 Jan; 4(2):260-81. PubMed ID: 26239127
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.
Hewavisenti RV; Arena J; Ahlenstiel CL; Sasson SC
Front Immunol; 2023; 14():1112513. PubMed ID: 36960048
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.
Harwood CA; Surentheran T; McGregor JM; Spink PJ; Leigh IM; Breuer J; Proby CM
J Med Virol; 2000 Jul; 61(3):289-97. PubMed ID: 10861635
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
6. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
Bacik LC; Chung C
Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727
[TBL] [Abstract][Full Text] [Related]
8. Genitoanal human papillomavirus infection and associated neoplasias.
Gross G
Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
[TBL] [Abstract][Full Text] [Related]
9. Flat Warts (Verrucae Planae) Confined to the Pigment of a Tattoo: A Rare Tattoo-associated Complication.
Filipović N; Tomas D; Buljan M
Acta Dermatovenerol Croat; 2023 Nov; 31(2):112-114. PubMed ID: 38006375
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus-related premalignant and malignant lesions of the cervix and anogenital tract in immunocompromised women.
Wielgos AA; Pietrzak B
Ginekol Pol; 2020; 91(1):32-37. PubMed ID: 32039466
[TBL] [Abstract][Full Text] [Related]
11. [Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management].
Krüger-Corcoran D; Stockfleth E; Jürgensen JS; Maltusch A; Nindl I; Sterry W; Lange-Asschenfeldt B; Ulrich C
Hautarzt; 2010 Mar; 61(3):220-9. PubMed ID: 20165825
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review.
Pham CT; Juhasz M; Sung CT; Mesinkovska NA
J Am Acad Dermatol; 2020 Jan; 82(1):202-212. PubMed ID: 31085272
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
14. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients.
Smith SE; Davis IC; Leshin B; Fleischer AB; White WL; Feldman SR
Arch Dermatol; 1993 Dec; 129(12):1585-8. PubMed ID: 8250579
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
[TBL] [Abstract][Full Text] [Related]
17. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infections: epidemiology, pathogenesis, and therapy.
Severson J; Evans TY; Lee P; Chan T; Arany I; Tyring SK
J Cutan Med Surg; 2001; 5(1):43-60. PubMed ID: 11281434
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus infection and skin cancer risk in organ transplant recipients.
Bouwes Bavinck JN; Feltkamp M; Struijk L; ter Schegget J
J Investig Dermatol Symp Proc; 2001 Dec; 6(3):207-11. PubMed ID: 11924829
[TBL] [Abstract][Full Text] [Related]
20. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients.
Meyer T; Arndt R; Nindl I; Ulrich C; Christophers E; Stockfleth E
Transpl Int; 2003 Mar; 16(3):146-53. PubMed ID: 12664208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
